Pro Medicus (ASX:PME) Insider Purchases A$134,400.00 in Stock

Pro Medicus Limited (ASX:PME) insider Peter Kempen bought 600 shares of the company’s stock in a transaction on Monday, December 29th. The stock was bought at an average cost of A$224.00 per share, with a total value of A$134,400.00.

Pro Medicus Stock Performance

The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10. The company has a market cap of $29.16 billion, a P/E ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.